Skip to content

Contract award record

NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B

Notice details

Published
Category
goods
Buyer region
North West

Public buyer and contract winner

Public buyer

NHS England
awarded to

Contract winner

CSL Behring UK Limited

Award value£192,000,000

  1. Awarded
    Completed
  2. Start
    Completed
  3. End
    Completed

Work description

NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B. The framework will commence on 1st March 2019 for a period of 24 months until 28th February 2021, with options to extend up to a further 24 month.

Related awards

From this public buyer

View all awards from this public buyer

Source: Contracts Finder · Notice 4b4175f9-e4ff-4ca9-a23b-79d639ae18c9-275483

View source notice